Key result
Tachycardia-induced cardiomyopathy is a potentially reversible cause of heart failure, with catheter ablation being the most effective treatment for restoring left ventricular function.
Tachycardia-induced cardiomyopathy is a frequently unrecognized but potentially reversible cause of heart failure that can be effectively treated with catheter ablation or other rhythm/rate control strategies to recover left ventricular function.
Recognition of tachycardia-induced cardiomyopathy is key in HF with tachyarrhythmias; leaves open optimal reversal strategies in prospective studies.
Cardiac arrhythmias often coexist with heart failure and can be its cause or consequence. Tachycardia-induced cardiomyopathy most often occurs as a consequence of persistent atrial tachyarrhythmias, such as atrial fibrillation and atrial flutter. Accelerated heart rate leads to systolic and diastolic dysfunction of the left ventricle with its consequent dilation together with changes at the neurohumoral and cellular levels. Clinical presentation varies from asymptomatic tachycardia to end-stage heart failure. Tachycardia-induced cardiomyopathy is an often unrecognized and potentially reversible cause of heart failure. The exact prevalence of tachycardiomyopathy is difficult to determine since the diagnosis is made retrospectively, based on echocardiographically confirmed recovery of the left ventricular function after adequate treatment of the arrhythmia. The most effective treatment is catheter ablation of the arrhythmia. Other treatments include electrical cardioversion, pharmacological rhythm and/ or rate control, and pacemaker implantation with ablation of the atrioventricular node
No takes yet. Share an insight, caveat, or question.
Kovacevic et al. (2023) conducted a review in Tachycardia-induced cardiomyopathy and heart failure. Catheter ablation and rate/rhythm control was evaluated. Tachycardia-induced cardiomyopathy is a potentially reversible cause of heart failure, with catheter ablation being the most effective treatment for restoring left ventricular function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: